T. Rowe Price Associates
CTRE icon

T. Rowe Price Associates’s CareTrust REIT CTRE Stock Holding History

T. Rowe Price Associates’s Portfolio CTRE Stock Details CTRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.9M Buy
242,839
+44,069
+22% +$1.69M ﹤0.01% 1243
2025
Q4 		$7.19M Buy
198,770
+20,084
+11% +$720K ﹤0.01% 1302
2025
Q3 		$6.2M Buy
178,686
+25,670
+17% +$844K ﹤0.01% 1338
2025
Q2 		$4.68M Buy
153,016
+17,139
+13% +$494K ﹤0.01% 1290
2025
Q1 		$3.88M Buy
135,877
+13,096
+11% +$352K ﹤0.01% 1327
2024
Q4 		$3.32M Buy
122,781
+36,976
+43% +$1.1M ﹤0.01% 1416
2024
Q3 		$2.65M Buy
85,805
+4,755
+6% +$135K ﹤0.01% 1514
2024
Q2 		$2.04M Buy
81,050
+12,516
+18% +$310K ﹤0.01% 1542
2024
Q1 		$1.67M Buy
68,534
+9,112
+15% +$206K ﹤0.01% 1663
2023
Q4 		$1.33M Sell
59,422
-419
-0.7% -$9.27K ﹤0.01% 1725
2023
Q3 		$1.23M Buy
59,841
+2,501
+4% +$50.6K ﹤0.01% 1706
2023
Q2 		$1.14M Buy
57,340
+2,592
+5% +$50.6K ﹤0.01% 1740
2023
Q1 		$1.07M Buy
54,748
+2,246
+4% +$43.9K ﹤0.01% 1754
2022
Q4 		$975K Sell
52,502
-5,073
-9% -$94.7K ﹤0.01% 1783
2022
Q3 		$1.04M Sell
57,575
-7,850
-12% -$160K ﹤0.01% 1726
2022
Q2 		$1.21M Buy
65,425
+3,782
+6% +$67.1K ﹤0.01% 1805
2022
Q1 		$1.19M Buy
61,643
+2,096
+4% +$41.3K ﹤0.01% 1915
2021
Q4 		$1.36M Sell
59,547
-1,710
-3% -$36.2K ﹤0.01% 1871
2021
Q3 		$1.25M Sell
61,257
-1,515
-2% -$34.2K ﹤0.01% 1938
2021
Q2 		$1.46M Sell
62,772
-2,948
-4% -$69.4K ﹤0.01% 1879
2021
Q1 		$1.53M Sell
65,720
-2,916
-4% -$67K ﹤0.01% 1839
2020
Q4 		$1.52M Sell
68,636
-1,686
-2% -$33.2K ﹤0.01% 1733
2020
Q3 		$1.25M Sell
70,322
-7,857
-10% -$143K ﹤0.01% 1714
2020
Q2 		$1.34M Sell
78,179
-17,343
-18% -$303K ﹤0.01% 1666
2020
Q1 		$1.41M Buy
95,522
+15,310
+19% +$304K ﹤0.01% 1596
2019
Q4 		$1.66M Buy
80,212
+17,388
+28% +$380K ﹤0.01% 1678
2019
Q3 		$1.48M Buy
62,824
+473
+0.8% +$11.1K ﹤0.01% 1661
2019
Q2 		$1.48M Buy
62,351
+6,777
+12% +$164K ﹤0.01% 1688
2019
Q1 		$1.3M Buy
55,574
+310
+0.6% +$6.79K ﹤0.01% 1733
2018
Q4 		$1.02M Buy
55,264
+13,002
+31% +$242K ﹤0.01% 1789
2018
Q3 		$748K Buy
42,262
+553
+1% +$9.74K ﹤0.01% 1989
2018
Q2 		$696K Buy
41,709
+82
+0.2% +$1.23K ﹤0.01% 2000
2018
Q1 		$558K Buy
41,627
+147
+0.4% +$2.17K ﹤0.01% 2046
2017
Q4 		$695K Buy
41,480
+22,200
+115% +$410K ﹤0.01% 1950
2017
Q3 		$367K Hold
19,280
– – ﹤0.01% 2206
2017
Q2 		$357K Buy
19,280
+25
+0.1% +$452 ﹤0.01% 2178
2017
Q1 		$324K Buy
19,255
+17
+0.1% +$264 ﹤0.01% 2223
2016
Q4 		$295K Hold
19,238
– – ﹤0.01% 2256
2016
Q3 		$284K Hold
19,238
– – ﹤0.01% 2237
2016
Q2 		$265K Sell
19,238
-9,940
-34% -$131K ﹤0.01% 2230
2016
Q1 		$371K Hold
29,178
– – ﹤0.01% 2083
2015
Q4 		$319K Buy
29,178
+9,400
+48% +$104K ﹤0.01% 2129
2015
Q3 		$224K Hold
19,778
– – ﹤0.01% 2255
2015
Q2 		$251K Hold
19,778
– – ﹤0.01% 2265
2015
Q1 		$268K Hold
19,778
– – ﹤0.01% 2237
2014
Q4 		$244K Buy
19,778
+6,478
+49% +$95.3K ﹤0.01% 2264
2014
Q3 		$190K Hold
13,300
– – ﹤0.01% 2361
2014
Q2 		$263K Buy
+13,300
New +$243K ﹤0.01% 2233

Other funds holding CTRE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

T. Rowe Price Associates's CTRE Position: Q1 2026 in Review

T. Rowe Price Associates increased its CareTrust REIT (CTRE) stake by 22% in Q1 2026, buying an estimated $1.69M and bringing the position to 242,839 shares worth $8.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1243.

T. Rowe Price Associates first reported a position in CTRE in Q2 2014 and has held it in 48 quarters since. 490 funds tracked by Wall St. Rank hold CTRE as of Q1 2026.

  • T. Rowe Price Associates held 242,839 shares of CareTrust REIT worth $8.9M as of Q1 2026.
  • T. Rowe Price Associates bought 44,069 CareTrust REIT shares in Q1 2026, an estimated $1.69M.
  • CareTrust REIT made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1243 holding.
  • T. Rowe Price Associates first reported a position in CareTrust REIT in Q2 2014 and has held it in 48 quarters since.
  • 490 funds tracked by Wall St. Rank held CareTrust REIT as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.